Related references
Note: Only part of the references are listed.G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1
Carina Hasenoehrl et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Fatty acid-binding protein FABP4 mechanistically links obesity with aggressive AML by enhancing aberrant DNA methylation in AML cells
F. Yan et al.
LEUKEMIA (2017)
N-Arachidonoyl Dopamine Inhibits NRAS Neoplastic Transformation by Suppressing Its Plasma Membrane Translocation
Min Wu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins
Sandra Guaita-Esteruelas et al.
MOLECULAR CARCINOGENESIS (2017)
Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis
Ester Pagano et al.
PHARMACOLOGICAL RESEARCH (2017)
Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5
Waseem Al-Jameel et al.
ONCOTARGET (2017)
Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism
Arianna Bettiga et al.
SCIENTIFIC REPORTS (2017)
Cannabidiol, a novel inverse agonist for GPR12
Kevin J. Brown et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
N-acyl dopamines induce apoptosis in PC12 cell line via the GPR55 receptor activation
M. G. Akimov et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2017)
Identification of diagnostic markers involved in the pathogenesis of gastric cancer through iTRAQ-based quantitative proteomics
Zhen Jiang et al.
DATA IN BRIEF (2017)
The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis
Koichiro Kawaguchi et al.
BIOCHEMICAL JOURNAL (2016)
Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors
William J. Redmond et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis
J. Kargl et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein
Huan Huang et al.
BIOCHEMISTRY (2016)
5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells
Seok-Woo Park et al.
BMC CANCER (2016)
N-acyl dopamines induce cell death in PC12 cell line via induction of nitric oxide generation and oxidative stress
A. M. Ashba et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2016)
Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015)
Yan-Ting Wang et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Antitumorigenic targets of cannabinoids - current status and implications
Robert Ramer et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
FABP-1 gene ablation impacts brain endocannabinoid system in male mice
Gregory G. Martin et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Comparing the effects of endogenous and synthetic cannabinoid receptor agonists on survival of gastric cancer cells
A. Ortega et al.
LIFE SCIENCES (2016)
Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels
Gregory G. Martin et al.
LIPIDS (2016)
Palmitoylethanolamide Exerts Antiproliferative Effect and Downregulates VEGF Signaling in Caco-2 Human Colon Carcinoma Cell Line Through a Selective PPAR--Dependent Inhibition of Akt/mTOR Pathway
Giovanni Sarnelli et al.
PHYTOTHERAPY RESEARCH (2016)
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti et al.
PROGRESS IN LIPID RESEARCH (2016)
FABP5 correlates with poor prognosis and promotes tumor cell growth and metastasis in cervical cancer
Wei Wang et al.
TUMOR BIOLOGY (2016)
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells
Katrin Winkler et al.
ONCOTARGET (2016)
Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma
Chung-Yu Ku et al.
ONCOTARGET (2016)
Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC)
Zhiyuan Tang et al.
ONCOTARGET (2016)
Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter
Farzad S. Forootan et al.
ONCOTARGET (2016)
A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
Dale G. Deutsch
Frontiers in Pharmacology (2016)
GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to N-Arachidonoyl Glycine
David B. Finlay et al.
PEERJ (2016)
Delta9-Tetrahydrocannabinol and Cannabidiol as Potential Curative Agents for Cancer: A Critical Examination of the Preclinical Literature
C. J. Fowler
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Cannabinoid Receptor 1 Promotes Hepatocellular Carcinoma Initiation and Progression Through Multiple Mechanisms
Bani Mukhopadhyay et al.
HEPATOLOGY (2015)
Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner
Massimo Nabissi et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Eduardo Perez-Gomez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms
Martin Kaczocha et al.
MOLECULAR PAIN (2015)
The Endocannabinoid System and its Modulation by Phytocannabinoids
Vincenzo Di Marzo et al.
NEUROTHERAPEUTICS (2015)
Proapoptotic effect of endocannabinoids in prostate cancer cells
O. Orellana-Serradell et al.
ONCOLOGY REPORTS (2015)
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer
Ling Chen et al.
ONCOLOGY REPORTS (2015)
Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma
Jiancheng Zhou et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
Inhibition of tumor growth by a newly-identified activator for epidermal fatty acid binding protein
Enyu Rao et al.
ONCOTARGET (2015)
Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability
Catherine A. Powell et al.
ONCOTARGET (2015)
Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo
Kazem Zibara et al.
SCIENTIFIC REPORTS (2015)
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Eduardo Perez-Gomez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Hydrogen-Bonded His93 As a Sensitive Probe for Identifying Inhibitors of the Endocannabinoid Transport Protein FABP7
Sergiy Tyukhtenko et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2015)
Anticancer effects of anandamide on head and neck squamous cell carcinoma cells via the production of receptor-independent reactive oxygen species
Seok-Woo Park et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
Differential Expression of Lipid Metabolism-Related Proteins in Different Breast Cancer Subtypes
Sewha Kim et al.
PLOS ONE (2015)
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor
Sandra Gouveia-Figueira et al.
PLOS ONE (2015)
Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors
Enrico Michelino Messalli et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2014)
Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1
Maria Haustein et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling
N. A. Balenga et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Molecular Biomarkers of Residual Disease after Surgical Debulking of High-Grade Serous Ovarian Cancer
Susan L. Tucker et al.
CLINICAL CANCER RESEARCH (2014)
Fatty acid binding proteins: tissue-specific functions in health and disease
Alfred E. Thumser et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2014)
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-
Maria Beatrice Morelli et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression
Hisanori Uehara et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The expression of C-FABP and PPAR gamma and their prognostic significance in prostate cancer
Farzad S. Forootan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
Estefania Moreno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors
Maija Hyvonen et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Expression of fatty acid binding protein 4 is involved in the cell growth of oral squamous cell carcinoma
Doksa Lee et al.
ONCOLOGY REPORTS (2014)
Mechanism of platelet activation induced by endocannabinoids in blood and plasma
S. Annette Brantl et al.
PLATELETS (2014)
Inhibition of Fatty Acid Binding Proteins Elevates Brain Anandamide Levels and Produces Analgesia
Martin Kaczocha et al.
PLOS ONE (2014)
Involvement of Fatty Acid Amide Hydrolase and Fatty Acid Binding Protein 5 in the Uptake of Anandamide by Cell Lines with Different Levels of Fatty Acid Amide Hydrolase Expression: A Pharmacological Study
Emmelie Bjorklund et al.
PLOS ONE (2014)
FABP7 and HMGCS2 Are Novel Protein Markers for Apocrine Differentiation Categorizing Apocrine Carcinoma of the Breast
Pavel Gromov et al.
PLOS ONE (2014)
Δ9-THC modulation of fatty acid 2-hydroxylase (FA2H) gene expression: Possible involvement of induced levels of PPARα in MDA-MB-231 breast cancer cells
Shuso Takeda et al.
TOXICOLOGY (2014)
Has FLAT fallen flat?
Christopher J. Fowler
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
Daniel J. Hermanson et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma
Masafumi Inoue et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Crystallographic study of FABP5 as an intracellular endocannabinoid transporter
Benoit Sanson et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2014)
Δ9-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: rnplications for signaling at GPR18
Douglas McHugh et al.
FRONTIERS IN PHARMACOLOGY (2014)
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck
Thomas J. W. Klein Nulent et al.
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY (2013)
Genetic Ablation of the Fatty Acid-Binding Protein FABP5 Suppresses HER2-Induced Mammary Tumorigenesis
Liraz Levi et al.
CANCER RESEARCH (2013)
Triggering of the TRPV2 channel by cannabidiol sensitizes glioblastoma cells to cytotoxic chemotherapeutic agents
Massimo Nabissi et al.
CARCINOGENESIS (2013)
Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK)
Alex T. Grupenmacher et al.
CHILDS NERVOUS SYSTEM (2013)
Anticancer activity of anandamide in human cutaneous melanoma cells
Barbara Adinolfi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells
Daniela Rovito et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells
Robert Ramer et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
Daniel J. Hermanson et al.
NATURE NEUROSCIENCE (2013)
The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas
E. Perez-Gomez et al.
ONCOGENE (2013)
Fatty acid binding protein 7 as a marker of glioma stem cells
Yusuke Morihiro et al.
PATHOLOGY INTERNATIONAL (2013)
A Gut Lipid Messenger Links Excess Dietary Fat to Dopamine Deficiency
Luis A. Tellez et al.
SCIENCE (2013)
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma
D. Vara et al.
CELL DEATH & DISEASE (2013)
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer
Chan Kwon Jung et al.
ONCOLOGY LETTERS (2013)
Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms
Mackenzie K. Herroon et al.
ONCOTARGET (2013)
N-Arachidonyl Glycine Does Not Activate G Protein-Coupled Receptor 18 Signaling via Canonical Pathways
Van B. Lu et al.
MOLECULAR PHARMACOLOGY (2013)
Recent Progress in Prostaglandin F2α Ethanolamide (Prostamide F2α) Research and Therapeutics
D. F. Woodward et al.
PHARMACOLOGICAL REVIEWS (2013)
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation
L. De Petrocellis et al.
ACTA PHYSIOLOGICA (2012)
The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action
Laurie Hamtiaux et al.
BMC CANCER (2012)
Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells
Douglas McHugh et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Fatty Acid-binding Proteins Transport N-Acylethanolamines to Nuclear Receptors and Are Targets of Endocannabinoid Transport Inhibitors
Martin Kaczocha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Overexpression of FABP3 promotes apoptosis through inducing mitochondrial impairment in embryonic cancer cells
Gui Xian Song et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Interaction of Endocannabinoid System and Steroid Hormones in the Control of Colon Cancer Cell Growth
Maria C. Proto et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
FABP4 is a candidate marker of cerebellar liponeurocytomas
Elena Anghileri et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Alteration of endocannabinoid system in human gliomas
Xiyue Wu et al.
JOURNAL OF NEUROCHEMISTRY (2012)
A catalytically silent FAAH-1 variant drives anandamide transport in neurons
Jin Fu et al.
NATURE NEUROSCIENCE (2012)
Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma
Chi-Young Jeong et al.
ONCOLOGY REPORTS (2012)
Why do cannabinoid receptors have more than one endogenous ligand?
Vincenzo Di Marzo et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Anandamide uptake explained?
Christopher J. Fowler
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Aberrant Expression of Retinoic Acid Signaling Molecules Influences Patient Survival in Astrocytic Gliomas
Benito Campos et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Association of FABP5 Expression With Poor Survival in Triple-Negative Breast Cancer Implication for Retinoic Acid Therapy
Rong-Zong Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes
Luciano De Petrocellis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer
Lin Ye et al.
CANCER LETTERS (2011)
Monoacylglycerol Lipase Exerts Dual Control over Endocannabinoid and Fatty Acid Pathways to Support Prostate Cancer
Daniel K. Nomura et al.
CHEMISTRY & BIOLOGY (2011)
Cyclin-dependent Kinase-associated Protein Cks2 is Associated with Bladder Cancer Progression
R. Chen et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2011)
Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55
Christopher M. Henstridge et al.
MOLECULAR ENDOCRINOLOGY (2011)
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2
Kelsey C. Duggan et al.
NATURE CHEMICAL BIOLOGY (2011)
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Kristin M. Nieman et al.
NATURE MEDICINE (2011)
The orphan G protein-coupled receptor GPR55 promotes cancer cell proliferation via ERK
C. Andradas et al.
ONCOGENE (2011)
The putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferation
R. Pineiro et al.
ONCOGENE (2011)
Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism
Laurie Hamtiaux et al.
PLOS ONE (2011)
Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells
Kasem Nithipatikom et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2011)
L-α-Lysophosphatidylinositol meets GPR55: a deadly relationship
Ruth A. Ross
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Pharmacology of capsaicin-, anandamide-, and N-arachidonoyl-dopamine-evoked cell death in a homogeneous transient receptor potential vanilloid subtype 1 receptor population
J. W. Davies et al.
BRITISH JOURNAL OF ANAESTHESIA (2010)
Inhibition of monoacylglycerol lipase by troglitazone, N-arachidonoyl dopamine and the irreversible inhibitor JZL184: comparison of two different assays
E. Bjorklund et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines
Iain Brown et al.
CARCINOGENESIS (2010)
Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis
Daniel K. Nomura et al.
CELL (2010)
The Levels of the Endocannabinoid Receptor CB2 and Its Ligand 2-Arachidonoylglycerol Are Elevated in Endometrial Carcinoma
Maurizio Guida et al.
ENDOCRINOLOGY (2010)
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis
Rosanna Cozzolino et al.
INVESTIGATIONAL NEW DRUGS (2010)
Brain Fatty Acid-binding Protein and ω-3/ω-6 Fatty Acids MECHANISTIC INSIGHT INTO MALIGNANT GLIOMA CELL MIGRATION
Raja Mita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Fatty Acid-binding Protein 5 and PPARβ/δ Are Critical Mediators of Epidermal Growth Factor Receptor-induced Carcinoma Cell Growth
Padmamalini Kannan-Thulasiraman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cannabinoid CB1 Receptor Is Downregulated in Clear Cell Renal Cell Carcinoma
Gorka Larrinaga et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2010)
Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma
Lei-Ya Fang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2010)
Mammary-derived growth inhibitor (MDGI) interacts with integrin α-subunits and suppresses integrin activity and invasion
J. Nevo et al.
ONCOGENE (2010)
Fatty Acid Amide Hydrolase in Prostate Cancer: Association with Disease Severity and Outcome, CB1 Receptor Expression and Regulation by IL-4
Lina Thors et al.
PLOS ONE (2010)
Intracellular trafficking of anandamide: new concepts for signaling
Mauro Maccarrone et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Differential Sensitivity and Mechanism of Inhibition of COX-2 Oxygenation of Arachidonic Acid and 2-Arachidonoylglycerol by Ibuprofen and Mefenamic Acid
Jeffery J. Prusakiewicz et al.
BIOCHEMISTRY (2009)
Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?
Angelika Toelle et al.
BMC CANCER (2009)
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2
N. Olea-Herrero et al.
BRITISH JOURNAL OF CANCER (2009)
Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors
Alvin R. King et al.
CHEMISTRY & BIOLOGY (2009)
A high cannabinoid CB1 receptor immunoreactivity is associated with disease severity and outcome in prostate cancer
Sui Chu Chung et al.
EUROPEAN JOURNAL OF CANCER (2009)
Time-dependent vascular actions of cannabidiol in the rat aorta
Saoirse E. O'Sullivan et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ Assay
Hong Yin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
R(+)-Methanandamide-Induced Apoptosis of Human Cervical Carcinoma Cells Involves A Cyclooxygenase-2-Dependent Pathway
Karin Eichele et al.
PHARMACEUTICAL RESEARCH (2009)
The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation
Vincenzo Di Marzo
PHARMACOLOGICAL RESEARCH (2009)
Identification of intracellular carriers for the endocannabinoid anandamide
Martin Kaczocha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Biology of endocannabinoid synthesis system
Jun Wang et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2009)
Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine
Andreas Artmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2008)
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth
Dingzhi Wang et al.
CANCER RESEARCH (2008)
Cannabinoids in pancreatic cancer:: Correlation with survival and pain
Christoph W. Michalski et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Expression and function of fatty acid amide hydrolase in prostate cancer
Michael P. Endsley et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Identification of farnesyl pyrophosphate and N-arachidonylglycine as endogenous ligands for GPR92
Da Young Oh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-n-acyl ethanolamine precursors in mouse brain
Gabriel M. Simon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons
Ning Qin et al.
JOURNAL OF NEUROSCIENCE (2008)
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8
Luciano De Petrocellis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1
Robert Ramer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Multiple pathways involved in the biosynthesis of anandamide
Jie Liu et al.
NEUROPHARMACOLOGY (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon
Angelo A. Izzo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects
D. G. Johns et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol
Jacqueline L. Blankman et al.
CHEMISTRY & BIOLOGY (2007)
Cannabinoid activation of PPARα;: a novel neuroprotective mechanism
Y. Sun et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding pirotein (aFABP)
Richard Sulsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy
Simona Pisanti et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Discovery and characterization of Ca2+-independent phosphatidylethanolarnine N-acyltransferase generating the anandarnide precursor and its congeners
Xing-Hua Jin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells
Chlara Laezza et al.
FEBS LETTERS (2006)
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma
Xundi Xu et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma
Kristin Gustafsson et al.
MOLECULAR PHARMACOLOGY (2006)
Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for α/β-hydrolase 4 in this pathway
Gabriel M. Simon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Fatty acid binding protein 6 is overexpressed in colorectal cancer
Takahiro Ohmachi et al.
CLINICAL CANCER RESEARCH (2006)
Identification of N-arachidonylglycine as the endogenous ligand for orphan G-protein-coupled receptor GPR18
Masashi Kohno et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Cannabinoid receptors in human astroglial tumors
Janka Held-Feindt et al.
JOURNAL OF NEUROCHEMISTRY (2006)
A pilot clinical study of Δ9- tetrahydrocannabinol in patients with recurrent glioblastoma multiforme
M. Guzman et al.
BRITISH JOURNAL OF CANCER (2006)
Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation
Maria M. Caffarel et al.
CANCER RESEARCH (2006)
A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy
Y Goto et al.
CANCER RESEARCH (2006)
Further characterization of the time-dependent vascular effects of Δ9-tetrahydrocannabinol
SE O'Sullivan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
HA Overton et al.
CELL METABOLISM (2006)
Anandamide inhibits adhesion and migration of breast cancer cells
C Grimaldi et al.
EXPERIMENTAL CELL RESEARCH (2006)
R(+)-methanandamide elicits a cyclooxygenase-2-dependent mitochondrial apoptosis signaling pathway in human neuroglioma cells
K Eichele et al.
PHARMACEUTICAL RESEARCH (2006)
Novel time-dependent vascular actions of Δ9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma
SE O'Sullivan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Mechanism of carbamate inactivation of FAAH: Implications for the design of covalent inhibitors and in vivo functional probes for enzymes
JP Alexander et al.
CHEMISTRY & BIOLOGY (2005)
Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids
M Steffens et al.
NEUROSCIENCE LETTERS (2005)
Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation
M Bouaboula et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue
G Petersen et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye
K Fujii et al.
PROTEOMICS (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation
M Bifulco et al.
FASEB JOURNAL (2004)
2-arachidonoylglycerol: A novel inhibitor of androgen-independent prostate cancer cell invasion
K Nithipatikom et al.
CANCER RESEARCH (2004)
Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells
B Hinz et al.
MOLECULAR PHARMACOLOGY (2004)
Assignment of endogenous substrates to enzymes by global metabolite profiling
A Saghatelian et al.
BIOCHEMISTRY (2004)
R(+)-methanandamide-induced cyclooxygenase-2 expression in H4 human neuroglioma cells:: possible involvement of membrane lipid rafts
B Hinz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D
YX Sun et al.
BIOCHEMICAL JOURNAL (2004)
Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmilssion in the rat isolated mesenteric arterial bed via a non-CB1/CB2Gi/o linked receptor
M Duncan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α
J Fu et al.
NATURE (2003)
Possible endocannabinoid control of colorectal cancer growth
A Ligresti et al.
GASTROENTEROLOGY (2003)
High level of cannabinoid receptor 1, absence of regulator of G protein signalling 13 and differential expression of Cyclin D1 in mantle cell lymphoma
TC Islam et al.
LEUKEMIA (2003)
Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading:: actions on signals involved in angiogenesis and metastasis
G Portella et al.
FASEB JOURNAL (2003)
Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines:: Implication of epidermal growth factor receptor down-regulation and ceramide production
M Mimeault et al.
PROSTATE (2003)
Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species
S Oka et al.
JOURNAL OF NEUROCHEMISTRY (2003)
High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity
J Adamson et al.
ONCOGENE (2003)
Anandamide and vanilloid TRPV1 receptors
RA Ross
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Anandamide and other N-acylethanolamines in human tumors
PC Schmid et al.
LIPIDS (2002)
Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells
M Maccarrone et al.
BIOCHEMICAL JOURNAL (2002)
Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems
L De Petrocellis et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2002)
An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
SM Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor
AC Porter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
2-arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid:: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain
S Nakane et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
De novo-synthesized ceramide is involved in cannabinoid-induced apoptosis
TG del Pulgar et al.
BIOCHEMICAL JOURNAL (2002)
Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues
F Fezza et al.
FEBS LETTERS (2002)
Anandamide receptors
V Di Marzo et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth
M Bifulco et al.
FASEB JOURNAL (2001)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB1 receptor-dependent G-protein activation in rat cerebellar membranes
JR Savinainen et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
L Hanus et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Control of the cell survival/death decision by cannabinoids
M Guzman et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture
M Maccarrone et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability
SOP Jacobsson et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Pathways and mechanisms of N-acylethanolamine biosynthesis:: can anandamide be generated selectively?
HHO Schmid
CHEMISTRY AND PHYSICS OF LIPIDS (2000)
Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2
KR Kozak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3
KP Sarker et al.
FEBS LETTERS (2000)
Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor -: Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells
T Sugiura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Suppression of nerve growth factor trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation
D Melck et al.
ENDOCRINOLOGY (2000)
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
I Galve-Roperh et al.
NATURE MEDICINE (2000)
Share Paper
